0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Niels C. Riedemann
Immunome
2 followers
Amgen
208 followers
Nagarro
13 followers
QIAGEN
8 followers
Australian National University Entrepreneurship Club
6 followers
Miami Foundation
2 followers
Capricor Therapeutics
1 follower
Elicio Therapeutics
1 follower
Nunzio Marc DeSantis Architects
1 follower
Scalable Capital
7 followers
DTCP
3 followers
Explore companies